Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
RESEARCH TOOLSreports
Holding ADAP?
Track your performance easily
See the Price Targets and Ratings of:
ADAP Analyst Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ADAP Stock 12 Month Forecast
Average Price Target
$2.88
▲(390.96% Upside)
| Highest Price Target$3.50 | Average Price Target$2.88 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
11/14/24
H.C. Wainwright
Reiterated
11/14/24
Scotiabank
Reiterated
11/14/24
Wells Fargo
Reiterated
11/14/24
Barclays
$1
Sell
70.47%
Upside
Assigned
08/13/24
Adaptimmune Therapeutics (ADAP) Gets a Sell from Barclays
Leerink Partners
$2
Hold
240.95%
Upside
Reiterated
08/12/24
Hold Rating on Adaptimmune Amid Commercialization and Financial Uncertainties
Mizuho Securities
―
Buy
―
Reiterated
08/06/24
Outperform Rating Affirmed for Adaptimmune Following FDA Approval and Positive Market Outlook for Tecelra
JonesTrading
$2.5→$2
Buy
240.95%
Upside
Reiterated
08/02/24
Buy Rating Affirmed for Adaptimmune on TECELRA's Market Potential and FDA Approval
Best Analysts Covering Adaptimmune Therapeutics
Which Analyst Should I Follow If I Want to Buy ADAP and Sell After:
1 Month
xxx
Success Rate
6/10 ratings generated profit
Average Return
+4.98%
assigned a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +4.98% per trade.
3 Months
xxx
Success Rate
5/10 ratings generated profit
Average Return
+3.46%
assigned a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.46% per trade.
1 Year
Success Rate
7/10 ratings generated profit
Average Return
+14.86%
assigned a sell rating 3 months ago
Copying Peter Lawson's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +14.86% per trade.
2 Years
xxx
Success Rate
7/10 ratings generated profit
Average Return
+11.83%
assigned a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 70.00% of your transactions generating a profit, with an average return of +11.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ADAP Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Nov 24
Strong Buy
8
6
5
6
8
Buy
3
3
2
3
3
Hold
9
7
5
3
4
Sell
3
2
1
2
2
Strong Sell
0
0
0
0
0
total
23
18
13
14
17
Each month's total comprises the sum of three months' worth of ratings.
ADAP Financial Forecast
ADAP Stock Forecast FAQ
What is ADAP’s average 12-month price target, according to analysts?
Based on analyst ratings, Adaptimmune Therapeutics’s 12-month average price target is $2.88.
What is ADAP’s upside potential, based on the analysts’ average price target?
Adaptimmune Therapeutics has 390.96% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ADAP a Buy, Sell or Hold?
Adaptimmune Therapeutics has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is Adaptimmune Therapeutics’s price target?
The average price target for Adaptimmune Therapeutics is $2.88. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $3.50 ,the lowest forecast is $2.00. The average price target represents 390.96% Increase from the current price of $0.587.
The highest analyst price target is $3.50 ,the lowest forecast is $2.00. The average price target represents 390.96% Increase from the current price of $0.587.
What do analysts say about Adaptimmune Therapeutics?
Adaptimmune Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of ADAP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.